This ones a heck of a specualive investment but it seems that the institutions are willing to stomp up the cash to back it in the long term.

Heres the latest news from Killik stocbrokers on the company..........

MEDICAL MARKETING Joint Venture

We recently highlighted Medical Marketing (MMG) as worthy of attention. The company, in which I have a personal share holding, has this morning announced the formation of a joint venture, Genvax, to develop a novel DNA vaccine platform technology.

Human trials have been underway since 2001 in areas such as Lymphoma and Myeloma but the technology has broad applications in cancer, viral and bacterial infections (hence the term platform). The technology works on boosting the immune system by teaching it to identify hard to recognise cancer proteins as foreign and destroy them. Early results from the 25 patient trial in lymphoma are encouraging and evaluation of the result is expected by March 2005. Successful results should mean big pharmaceutical groups will start to take financial and commercial interests around that time.

This looks to be the first of a series of announcements due from Medical Marketing as it has a range of predominantly cancer trials moving into the clinical stage. (news flow could push the price higher)

The stock has made good progress in recent sessions up to the mid-80p level where the company is valued at just under 40 million. ENDS.

Please DYOR

cheers GF.

Good news flow Mitzy, thanks.
Still picking my entry point but best be before 26th.
What a shite day folks, good buying opportunities unless yanks drop again, then next week might be even better?
GF, thanks for you note, wish you didn't mention dentists, my turn 1st thing Monday!!

Im waiting to get back in too andy ,but everything of mine is a sea of red,and i need to sell something to buy back MMG,its a vicious circle at the moment..
Hope next weeks better..JB..

share price continue to tick up with many sells, why?

JB, fortunately I still have my cash left from taking profits this year and only have 4 stocks at moment. Yanks hammered again on Friday, could be good buying opportunity next week. Mayiguo, Pharmas & drug stocks one of few areas to survive last few days due to good news in the sector, forget who though.
GF, do you think the shorting has finished now and its in a steady range 180-195 until next news?

BUY confirmed on Britishbulls

Cant say anything with confidence at the moment Andy as the general market and the US is determining share prices. Just have to say Fridays peformance was very good considering the general state of the market.

Nice to see Tom Winnifrith being very bullish this evening and talking down the scare mongerers.

cheers GF.

Tomorrow should be up for MMG

Yes its done very well considering the general market state over the last 3 days. Shown some real resilience.

cheers GF.

Still waiting to get back in on this GF,,if the market picks up,, im in ..JB.

Similar to Friday taking a tonking but came back at the end.

Nothing you can do in a market like this but take it on the chin and dream of the dot com days LOL. I think after the storm we will be ok. Seen this many times before except for the pre opening farce. So many stocks marked down and also so many being able to sell before the market was open at 8 am. Anyone see all that activity, it should be stopped by the London Stock Exchange.

cheers GF.

Yes i thought the same GF, thats not playing on a level field for some..JB..

Well MMGs fighting back, if we are to beleive the buy and sell figures we have more shares bought than sold.

cheers GF.

Lets just hope the markets settle down before the good news comes out.
DB66

Wish I'd stayed in bed. I'm with you GF. There are a few things the LSE should sort out.

Found this from you know where.

Insinger short term price target is 275p

Optimist at large - 18 Apr'05 - 07:06 - 5052 of 5062


MEDICAL MARKETING INTERNATIONAL GROUP PLC


NOTIFICATION OF R&D DAY

Date: Tuesday 26 April 2005

Medical Marketing International Group plc (LSE: MMG), the Cambridge, UK-based
pharmaceutical development company announces that it is to hold an R&D day on
Tuesday 26 April, 2005 at Buchanan Communications, 107 Cheapside, London EC2V
6DN.


MMI is an emerging UK-based biopharmaceutical company focussed principally on
the development of potential therapies in commercially attractive therapeutic
areas, such as cancer and infectious disease.


The presentations will focus primarily on two of MMI's key therapeutic programs,
from the joint venture Genvax and the wholly owned subsidiary Oncosense.
Genvax's development of cancer therapies is based on a proprietary DNA vaccine
platform technology about which clinical trials data has recently been
announced. Oncosense is focused on developing anticancer technologies, using
organo-metal compounds of the precious metal ruthenium as cytotoxic drugs.


An overview on Genvax's vaccine technology will be given by Freda Stevenson,
Professor of Immunology at the University of Southampton and a world-renowned
expert on DNA cancer vaccines. An overview on the scientific developments in
ruthenium compounds will be presented by Peter Sadler, Crum Brown Chair of
Chemistry at the University of Edinburgh, who is a leading authority on
organo-metallic chemistry with medical application.


Commenting on the forthcoming R&D Day, David Best, Chairman of MMI said: "The
team at MMI is extremely excited to be holding its first R&D day. Importantly,
the world class experts Professors Stevenson and Sadler as inventors of these
technologies describe some of the exciting products that are being progressed in
MMI's therapeutic portfolio. The R&D day will also be attended by key people
from the MMI team who will be available to answer questions. We hope that this R
&D day will lead to investors being better informed about MMI."

For further information, please contact:

David Best, Chairman
MMI Group Tel: +44 (0)1223 477677
www.mmigroup.co.uk

Lisa Baderoon/Rebecca Skye Dietrich
Buchanan Communications Tel: +44 (0)20 7466 5000

MS

Good find Mickey. Still has the potential to jump back intothe blue this one, like it did friday. Buys outnumber sells if the figures are correct.

cheers GF.

Buyers certainly coming back in now and its moved up again.

cheers GF.

dows up a tad....... should see our small caps back up now.... fingers crossed
rob

bugger..... now its down.sorry

No late run up from this one yet, mind theres still time.

cheers GF